Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 3–3 | Cite as

EMA adopts positive opinion for andexanet alfa

News item
  • 15 Downloads

References

  1. 1.
    European Medicines Agency. First antidote for reversal of anticoagulation with factor Xa inhibitors apixaban and rivaroxaban. Internet Document : 1 Mar 2019. Available from: URL: https://www.ema.europa.eu/en/news/first-antidote-reversal-anticoagulation-factor-xa-inhibitors-apixaban-rivaroxaban
  2. 2.
    Portola Pharmaceuticals Inc. European CHMP Adopts Positive Opinion on Ondexxya(TM) (andexanet alfa) Portola Pharmaceuticals Factor Xa Inhibitor Reversal Agent. Internet Document : 1 Mar 2019. Available from: URL: https://www.globenewswire.com/news-release/2019/03/01/1745215/0/en/European-CHMP-Adopts-Positive-Opinion-on-Ondexxya-andexanet-alfa-Portola-Pharmaceuticals-Factor-Xa-Inhibitor-Reversal-Agent.html

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations